Cargando…
Knockdown of Peroxiredoxin V increased the cytotoxicity of non-thermal plasma-treated culture medium to A549 cells
Administration of non-thermal plasma therapy via the use of plasma-activated medium (PAM) might be a novel strategy for cancer treatment, as it induces apoptosis by increasing reactive oxygen species (ROS) levels. Peroxiredoxin V (PRDX5) scavenges ROS and reactive nitrogen species and is known to re...
Autores principales: | Sun, Hu-Nan, Guo, Xiao-Yu, Xie, Dan-Ping, Wang, Xiao-Ming, Ren, Chen-Xi, Han, Ying-Hao, Yu, Nan-Nan, Huang, Yu-Lan, Kwon, Taeho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134956/ https://www.ncbi.nlm.nih.gov/pubmed/35546738 http://dx.doi.org/10.18632/aging.204063 |
Ejemplares similares
-
Regulatory function of peroxiredoxin I on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer development
por: Sun, Hu-Nan, et al.
Publicado: (2021) -
Peroxiredoxin II with dermal mesenchymal stem cells accelerates wound healing
por: Jin, Mei-Hua, et al.
Publicado: (2021) -
An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib
por: Kwon, Taeho, et al.
Publicado: (2015) -
Peroxiredoxin II regulates exosome secretion from dermal mesenchymal stem cells through the ISGylation signaling pathway
por: Han, Ying-Hao, et al.
Publicado: (2023) -
Peroxiredoxin 5 protects HepG2 cells from ethyl β-carboline-3-carboxylate-induced cell death via ROS-dependent MAPK signalling pathways
por: Xie, Dan-Ping, et al.
Publicado: (2022)